Cargando…
Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca(2+)/calmodulin signaling
TNF-related apoptosis-inducing ligand (TRAIL) is a promising cytokine for killing tumor cells. However, a number of studies have demonstrated that different cancer cells resist TRAIL treatment and, moreover, TRAIL can promote invasion and metastasis in resistant cells. Here we report that TRAIL rapi...
Autores principales: | Kaminskyy, V O, Surova, O V, Piskunova, T, Zborovskaya, I B, Tchevkina, E M, Andera, L, Zhivotovsky, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613829/ https://www.ncbi.nlm.nih.gov/pubmed/23470529 http://dx.doi.org/10.1038/cddis.2013.51 |
Ejemplares similares
-
Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL
por: Vaculova, Alena, et al.
Publicado: (2010) -
Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11
por: Zagryazhskaya, Anna, et al.
Publicado: (2015) -
Correction: Tudor staphylococcal nuclease drives chemoresistance of non-small cell lung carcinoma cells by regulating S100A11
por: Zagryazhskaya, Anna, et al.
Publicado: (2016) -
Cell death-based treatment of various diseases: a fifty-year journey
por: Kaminskyy, Vitaliy O., et al.
Publicado: (2018) -
Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC
por: Liu, Shuang, et al.
Publicado: (2021)